G01N 2800/40
Disorders due to exposure to physical agents
Official title: Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness
G01N2800/40 (Disorders due to exposure to physical agents) appears on 64 US grants and 128 published applications in this corpus.
Search patents in G01N- Granted patents
- 64
- Published applications
- 128
- Assignees
- 89
- Inventors
- 298
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 6 |
| 2009 | 0 | 9 |
| 2010 | 1 | 4 |
| 2011 | 3 | 7 |
| 2012 | 1 | 5 |
| 2013 | 3 | 6 |
| 2014 | 7 | 9 |
| 2015 | 6 | 8 |
| 2016 | 0 | 6 |
| 2017 | 4 | 5 |
| 2018 | 3 | 8 |
| 2019 | 4 | 6 |
| 2020 | 8 | 6 |
| 2021 | 3 | 10 |
| 2022 | 2 | 8 |
| 2023 | 4 | 6 |
| 2024 | 4 | 9 |
| 2025 | 2 | 5 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biodosimetry panels and methods16 Jun 2026US 12,658,304 B2Meso Scale Technologies, LLC.
- Methods and kits for detecting tau12 May 2026US 12,624,388 B2Meso Scale Technologies, LLC.
- Device, system and process for robotic radiobiology7 Apr 2026US 12,595,459 B2University Health Network
- Astrocyte traumatome and neurotrauma biomarkers24 Jun 2025US 12,339,289 B2The Regents of the University of California
- Device and methods14 Jan 2025US 12,196,656 B2Epona Biotech Ltd
- Methods and kits for detecting tau6 Aug 2026US 2026/0226534 A1Meso Scale Technologies, LLC.
- Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent9 Jul 2026US 2026/0191823 A1Kyowa Hakko Bio Co., Ltd.
- Astrocyte traumatome and neurotrauma biomarkers23 Apr 2026US 2026/0110699 A1The Regents of the University of California
- Blood biomarkers of oligodendrocyte-derived exosomes and their use in identifying asymptomatic brain injury2 Oct 2025US 2025/0306038 A1Nanosomix, Inc.
- Method of preventing overtraining, or determining the appropriate amount of exercise3 Jul 2025US 2025/0213923 A1
Most cited
By later US patents
- Reagents and methods for releasing and measuring lead ions from biological matrices11US 5,891,736 ABayer Aktiengesellschaft · 1999
- Reagents and methods for releasing and measuring lead ions from biological matrices9US 6,323,036 B1Bayer Aktiengesellschaft · 2001
- Diagnosis for porcine malignant hyperthermia7US 5,358,649 AThe University of Toronto Innovations Foundation · 1994
- Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment7US 8,062,222 B2Litron Laboratories, Ltd. · 2011
- Biodosimetry panels and methods5US 10,436,784 B2Meso Scale Technologies, LLC. · 2019